Insight, analysis & opinion from Joe Paduda

< Back to Home

Jun
7

Physician dispensed meds

If you want to know why you are getting more physician bills with meds on them, it’s simple – physician dispensing generates big profits.


There are currently at least 18 firms promoting their ability to help physicians maximize profits by dispensing medications. From one site comes this pitch:
“The Profit Projections Chart below shows how participation in our customized MD DispenseIT™ program can provide practicing physicians with a 30-50% increase in their Medical Practice Profits™”
This is of particular interest to workers comp payers.
A thanks to George Furlong for the heads-up.


3 thoughts on “Physician dispensed meds”

  1. Just be careful not to tar all situations with the same brush. In oncology, doctors are starting to add physician dispensing, as the pipeline holds more oral oncology products. However, there is almost no profit in oncology practice physician dispensing. Practices are starting to add dispensing, however, because the toxicity of cancer treatment, whether the orals are for treatment or side effects, makes it essential that the oncologist track patient compliance and even source of the drugs. We have seen too much counterfeiting and mishandling of delicate oncology drugs to trust patient survival and treatment to mass mailings and secondary wholesalers.

  2.  
    Interesting and thought-provoking post, Joe!
    Dawn’s insights notwithstanding (I have no reason to doubt her assertions), I still see no problem with physicians earning extra $$ dispensing appropriate meds.
    This is of a piece with the general move within the provider community to offer more “value added services;” to help shore up revenue lost when Medicare & UHC and BX (and the other usual suspects) keep lowering reimbursement costs.
    As long as the patient isn’t hurt (physically or financially), where’s the beef?
     

  3. The problem is not with physicians earning profits by dispensing appropriate medications. The problem is the extreme markup above retail reimbursement rates that WC payors are subject to for these medications with no significant value added benefit

Comments are closed.

Joe Paduda is the principal of Health Strategy Associates

SUBSCRIBE BY EMAIL

SEARCH THIS SITE

A national consulting firm specializing in managed care for workers’ compensation, group health and auto, and health care cost containment. We serve insurers, employers and health care providers.

 

DISCLAIMER

© Joe Paduda 2024. We encourage links to any material on this page. Fair use excerpts of material written by Joe Paduda may be used with attribution to Joe Paduda, Managed Care Matters.

Note: Some material on this page may be excerpted from other sources. In such cases, copyright is retained by the respective authors of those sources.

ARCHIVES

Archives